The healthcare market is rapidly evolving toward a value-based payment and delivery system with significant business implications for laboratories. Specifically, these value reform dynamics pose either a threat or an opportunity for labs depending on how financially-at-risk providers view the clinical contribution of lab services. Because they impact physician decision making, direct personalizing therapies, support population care management and accurately predict cost and outcome risk, laboratory services can bring tremendous value to Accountable Care Organizations (ACOs), one of the primary new delivery models in value-based care. Further opportunities are available for laboratories to deliver value generation solutions for providers in the coagulation disorder area. Dr. Herriman provides examples of both opportunities and makes the case for laboratories to pursue these new types of offerings now.